Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Slim Fourati

Showing results (11-20 of 185) with videos related to

Pageof 19
Sort By:
Annals of Intensive Care|July 15, 2024
COVID-19 associated pulmonary aspergillosis in critically-ill patients - authors' replyPierre Bay, Etienne Audureau, Slim Fourati, et al.
Intensive Care Medicine|April 16, 2020
Antiviral treatment strategy should be individualized in critically ill patients with severe influenzaFaten May, Slim Fourati, Armand Mekontso Dessap, et al.
Current Opinion in Immunology|July 9, 2016
Systems biology and the quest for correlates of protection to guide the development of an HIV vaccineLeticia Kuri-Cervantes, Slim Fourati, Glenda Canderan, et al.
The Lancet. Haematology|February 4, 2021
Allogeneic haematopoietic stem cell transplantation from SARS-CoV-2 positive donorsMathieu Leclerc, Slim Fourati, Dehbia Menouche, et al.
The Lancet. Haematology|September 6, 2021
Antibody response after third BNT162b2 dose in recipients of allogeneic HSCTRabah Redjoul, Anne Le Bouter, Vincent Parinet, et al.
Lancet (London, England)|July 16, 2021
Antibody response after second BNT162b2 dose in allogeneic HSCT recipientsRabah Redjoul, Anne Le Bouter, Florence Beckerich, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
Replication-attenuated r3LCMV vectors potentiate tumor control via IFN-IYoung Rock Chung, Bakare Awakoaiye, Tanushree Dangi, et al.
Intensive Care Medicine|June 24, 2020
SARS-CoV-2 viral loads and serum IgA/IgG immune responses in critically ill COVID-19 patientsSlim Fourati, Sophie Hue, Jean-Michel Pawlotsky, et al.
The Journal of Clinical Investigation|June 11, 2024
An attenuated lymphocytic choriomeningitis virus vector enhances tumor control in mice partly via IFN-IYoung Rock Chung, Bakare Awakoaiye, Tanushree Dangi, et al.
American Journal of Infection Control|February 28, 2016
Laboratory-based strategy using a new marketed polymerase chain reaction assay to manage diarrheic episodes among patients from rehabilitation and long-term care facilitiesMaud Salmona, Sarah Jolivet, Marion Duprilot, et al.
Pageof 19

Showing results (11-20 of 185) with videos related to

Sort By:
Pageof 19
Annals of Intensive Care|July 15, 2024
COVID-19 associated pulmonary aspergillosis in critically-ill patients - authors' replyPierre Bay, Etienne Audureau, Slim Fourati, et al.
Intensive Care Medicine|April 16, 2020
Antiviral treatment strategy should be individualized in critically ill patients with severe influenzaFaten May, Slim Fourati, Armand Mekontso Dessap, et al.
Current Opinion in Immunology|July 9, 2016
Systems biology and the quest for correlates of protection to guide the development of an HIV vaccineLeticia Kuri-Cervantes, Slim Fourati, Glenda Canderan, et al.
The Lancet. Haematology|February 4, 2021
Allogeneic haematopoietic stem cell transplantation from SARS-CoV-2 positive donorsMathieu Leclerc, Slim Fourati, Dehbia Menouche, et al.
The Lancet. Haematology|September 6, 2021
Antibody response after third BNT162b2 dose in recipients of allogeneic HSCTRabah Redjoul, Anne Le Bouter, Vincent Parinet, et al.
Lancet (London, England)|July 16, 2021
Antibody response after second BNT162b2 dose in allogeneic HSCT recipientsRabah Redjoul, Anne Le Bouter, Florence Beckerich, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
Replication-attenuated r3LCMV vectors potentiate tumor control via IFN-IYoung Rock Chung, Bakare Awakoaiye, Tanushree Dangi, et al.
Intensive Care Medicine|June 24, 2020
SARS-CoV-2 viral loads and serum IgA/IgG immune responses in critically ill COVID-19 patientsSlim Fourati, Sophie Hue, Jean-Michel Pawlotsky, et al.
The Journal of Clinical Investigation|June 11, 2024
An attenuated lymphocytic choriomeningitis virus vector enhances tumor control in mice partly via IFN-IYoung Rock Chung, Bakare Awakoaiye, Tanushree Dangi, et al.
American Journal of Infection Control|February 28, 2016
Laboratory-based strategy using a new marketed polymerase chain reaction assay to manage diarrheic episodes among patients from rehabilitation and long-term care facilitiesMaud Salmona, Sarah Jolivet, Marion Duprilot, et al.
Pageof 19